Publications
Detailed Information
Preventive effects of COX-2 inhibitor, celecoxib on renal tubular injury induced by shock wave lithotriptor
Cited 9 time in
Web of Science
Cited 9 time in Scopus
- Authors
- Issue Date
- 2010-08
- Publisher
- SPRINGER
- Citation
- UROLOGICAL RESEARCH; Vol.38; no.4; 223-228
- Keywords
- Kidney ; COX-2 inhibitors ; Extracorporeal shockwave lithotripsy
- Abstract
- Our study was designed to investigate the protective
eVect of the COX-2 inhibitor, celecoxib, on renal
tubules against shock wave lithotripsy (SWL). Sprague–
Dawley rats were randomly divided into three groups:
sham, control, and COX-2 groups. The control group was
administrated normal saline. The COX-2 group was administered
celecoxib (10 mg/kg). After administration for
1 week, the control and COX-2 groups received 1,000
shock waves. Before and after SWL, 24-h urine was collected.
CCr was measured to assess renal function. To
determine the renal tubular injury, N-acetyl glucosaminidase
(NAG) and -2 microglobulin levels in urine were
quantiWed. The COX-2 gene expression was compared
between the three groups. Prior to SWL, all groups had
similar levels of NAG and -2 microglobulin. After SWL,
all groups showed similar CCr. Compared with the sham
group, control and COX-2 groups produced increase of
NAG and -2 microglobulin excretion. However, NAG and
-2 microglobulin excretions were signiWcantly lower in
the COX-2 group than control group. The COX-2 gene expression did not increase in the sham group. However,
the COX-2 gene expression was signiWcantly increased in
the control group, which was prevented by celecoxib in
COX-2 group. Biochemical Wndings supported a renal protective
eVect of celecoxib on SWL. This study suggests that
celecoxib would be useful prior and after SWL because of
renal protective eVects.
- ISSN
- 0300-5623
- Language
- English
- Files in This Item:
- There are no files associated with this item.
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.